David T. Howton, EVP, General Counsel at Sarepta Therapeutics, Inc. (SRPT), sold 154,974 shares at $168.61 ($26.4M) on 2020-06-22, disclosed to the SEC on 2020-06-22.
Open-market sale of $26.4M SRPT by EVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $168.61 | 6,009 | $1.0M | 3.8% |
| 2 | $168.61 | 6,009 | $1.0M | 3.8% |
| 3 | $169.56 | 8,086 | $1.4M | 5.2% |
| 4 | $169.56 | 8,086 | $1.4M | 5.2% |
| 5 | $170.59 | 35,757 | $6.1M | 23.1% |
| 6 | $170.59 | 35,757 |
| $6.1M |
| 23.1% |
| 7 | $171.50 | 55,270 | $9.5M | 35.8% |
| Total | $170.65 avg | 154,974 | $26.4M | 100% |
| Filing → |
| SLDB | SELL | 2026-02-02 | $486K | — | Filing → |
| SLDB | SELL | 2025-12-04 | $25K | — | Filing → |
| SLDB | SELL | 2025-02-18 | $22K | — | Filing → |